KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

AbCellera Biologics (ABCL) Depreciation & Amortization - Total: 2021-2024

Historic Depreciation & Amortization - Total for AbCellera Biologics (ABCL) over the last 4 years, with Dec 2024 value amounting to $12.5 million.

  • AbCellera Biologics' Depreciation & Amortization - Total rose 39.89% to $3.9 million in Q4 2023 from the same period last year, while for Dec 2023 it was $12.9 million, marking a year-over-year increase of 43.52%. This contributed to the annual value of $12.5 million for FY2024, which is 2.05% down from last year.
  • As of FY2024, AbCellera Biologics' Depreciation & Amortization - Total stood at $12.5 million, which was down 2.05% from $12.8 million recorded in FY2023.
  • In the past 5 years, AbCellera Biologics' Depreciation & Amortization - Total ranged from a high of $12.8 million in FY2023 and a low of $4.4 million during FY2021.
  • For the 3-year period, AbCellera Biologics' Depreciation & Amortization - Total averaged around $11.4 million, with its median value being $12.5 million (2024).
  • In the last 5 years, AbCellera Biologics' Depreciation & Amortization - Total soared by 104.41% in 2022 and then decreased by 2.05% in 2024.
  • Over the past 4 years, AbCellera Biologics' Depreciation & Amortization - Total (Yearly) stood at $4.4 million in 2021, then soared by 104.41% to $9.0 million in 2022, then spiked by 42.22% to $12.8 million in 2023, then dropped by 2.05% to $12.5 million in 2024.